ANAPA BIOTECH A/S: Financial statements 2015
CVR: 27585167
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
ANAPA BIOTECH A/S (CVR 27585167) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -589,000 and a net result of DKK -14,384,000 compared with DKK -1,825,000 the year before. Equity in the 2015 report amounted to DKK 36,695,000. The solvency ratio was 99.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -589,000
- Profit/Loss
- DKK -14,384,000
- Equity
- DKK 36,695,000
- Total Assets
- DKK 36,886,000
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -589K | -14.4M | 36.7M | 2 |
| 2014 | - | -1.3M | -1.8M | 51.1M | 5 |
| 2013 | - | -2.4M | -2.8M | 50.7M | 7 |
| 2012 | 0 | -2.6M | -2.8M | 32.5M | - |
Official annual report
How creditworthy is ANAPA BIOTECH A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of November 1, 2015, K P M G C JESPERSEN ÅRHUS I/S has stepped down as auditor of ANAPA BIOTECH A/S.
As of June 8, 2015, Torben Ørskov Pedersen has left the board of directors of ANAPA BIOTECH A/S.
ANAPA BIOTECH A/S has published its annual report for 2014. Gross profit came to DKK -1,317,000, and the net result was DKK -1,825,000.
About ANAPA BIOTECH A/S
ANAPA BIOTECH A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named QUANTIBACT A/S and LNA BACTERIAL DETECTION A/S. The management consists of Søren Morgenthaler Echwald. The board consists of Anette Kofod Echwald (chair), Caroline Marie Morgenthaler Echwald and Søren Morgenthaler Echwald. The company is owned by Apana Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 263,027 and a net result of DKK 488,982 compared with DKK 7,646,635 the year before. Equity in the 2025 report amounted to DKK 10,970,173.